Tofacitinib Citrate Reference Standard
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

540737-29-9Tofacitinib Citrate Reference Standard

● In Stock

Catalogue No.:VE0011333
CAS No.:540737-29-9
Mol. Formula:C22H28N6O8
Mol. Weight:504.49 g/mol

Additional information on CAS 540737-29-9

Parent drug

Tofacitinib

IUPAC Name

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile; 2-Hydroxy-1,2,3-propanetricarboxylate

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

C[C@H]1[C@H](CN(CC1)C(CC#N)=O)N(C2=NC=NC3=C2C=CN3)C.OC(CC(O)(CC(O)=O)C(O)=O)=O

InChI

InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1

Shipping Condition

Ambient Temperature

Description

Tofacitinib Citrate Reference Standard, CAS 540737-29-9, is a characterized reference material provided for analytical laboratories and research organizations. Supplied with a comprehensive certificate of analysis, it is documented for identity and quality by relevant analytical techniques such as HPLC, NMR, mass spectrometry, and FT-IR, together with other applicable quality attributes including melting point, loss on drying, specific rotation, solubility, and other physicochemical parameters where applicable. This reference standard is suitable for analytical laboratory use requiring consistent and well-documented reference material.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url